Regular inhaled beta agonist in asthma: effects on exacerbations and lung function - Wikidata - wikimedia - TriplyDB

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

http://www.wikidata.org/entity/Q36274606

about

Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged high-throughput biophysical screening Interactions between corticosteroids and beta agonists.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Cardioselective beta-blockers for reversible airway disease.Low dose inhaled corticosteroids and the prevention of death from asthma.Long-acting inhaled beta(2)-agonist therapy in asthma.Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo.Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.Mast cells in airway diseases and interstitial lung disease Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors.The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study Risk versus benefit considerations for the beta(2)-agonists.North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults.Rates of admission to hospital for asthma Use of beta 2 agonists in asthma: much ado about nothing? Adverse effects are not proved.Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field.Adverse effects of salmeterol in asthma: a neuronal perspective.Safe use of long-acting β-agonists: what have we learnt?Mast cells in asthma--state of the art.Beta-Adrenergic Agonists Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.Glucocorticoid resistance in asthma.Salmeterol: an inhaled beta 2-agonist with prolonged duration of action.Efficacy and safety of inhaled corticosteroids. New developments.Salmeterol and cytokines modulate inositol-phosphate signalling in human airway smooth muscle cells via regulation at the receptor locus.Heat Shock-Related Protein 20 Peptide Decreases Human Airway Constriction Downstream of β2-Adrenergic Receptor.Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study.A clinical trial of the Buteyko Breathing Technique in asthma as taught by a video.Racemic salbutamol administration to guinea-pigs selectively augments airway smooth muscle responsiveness to cholinoceptor agonists.Risk of severe asthma episodes predicted from fluctuation analysis of airway function.beta2-Adrenoceptor agonist modulates endothelin-1 receptors in human isolated bronchi.Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.Therapeutic controversies in the treatment of asthma.

P2860

Q24200804-758A6F0C-4EF0-4D5D-A7FA-E87877877914 Q24202489-549A143C-DC73-46A5-B85A-8BA4FD528277 Q33792594-8DA144C9-B9DB-465B-8FD1-DBA7C0E1BC2D Q33944522-CB4985D3-97A9-4F21-AA72-3CC73B887546 Q33976334-330D098B-B676-4BC7-84A7-1E9A1FFCB6A4 Q34116299-002200F1-2FFA-4E74-A5FE-6E001296453E Q34342101-5FE969F5-54AD-47E1-A0D4-D766FEB71AA2 Q34392656-AD9DB21E-EFFC-4212-97D1-0DC2628B27D2 Q34698968-21909546-536F-4D93-8818-774CB42656C2 Q34712368-DDF147B6-B6A6-4E90-8C05-4B48C4D6D35F Q35127998-301CCB6D-F989-4F34-B5F4-CF6882A9D98E Q35532670-3D44E9D1-C38C-4A94-9BE2-48736F63BF89 Q35533126-7C61E2BF-8042-4F21-A879-A8450A996FA2 Q35627925-43452A5F-FC11-4252-95CC-E07BC8B4AB9D Q35749992-094A4C03-8069-4204-8406-234AC9D3E059 Q36260500-8CA95520-E651-4F0E-9CAB-B39CB98A3122 Q36389176-EEA8A190-E379-4A36-B523-1201932848C8 Q36477727-4FCB9770-593E-4642-B2A9-A90BB98DA884 Q36582709-3B3CD38C-1D8F-4B39-AD68-733BD1D7F281 Q36597554-99D4284F-A1E1-4B47-B1CE-4C2B3EA9F168 Q36885936-C7861F20-8CF4-4090-A7F5-E4272C9AEBCF Q36886978-1ECDE3A7-F478-44BE-B803-7BE375B4C3C2 Q36918110-6B63C98A-3F2B-4B38-95A1-17EC6AB6531B Q37314867-C0367952-42A9-49D0-A94E-4D578B03614A Q37869146-A9BEF533-EF71-4A84-9D8D-5A4F11B81A37 Q38633155-ED99918E-3E28-4756-B188-2029DC291985 Q38974241-91ED9800-37E6-495B-928E-4727B9F1959A Q39289487-5B2106A9-B7FD-45B6-A465-28ABBB37FA8B Q40376003-5A8ABF6D-4BE8-464C-8192-54FF32FE82FC Q40713319-F2F24924-E067-4C57-8387-8EC76E985798 Q41728966-5EE11992-7F31-422E-B293-34FF0AFDCB94 Q41877448-0A12A5D5-3B08-444D-B98E-C43966A110D3 Q42368298-DCE7EFD1-1154-4C23-AC7F-C64E709C3DA7 Q42545688-66E0D514-0F0F-4B19-B389-8A960BC0C974 Q43569075-3C793219-8945-48FF-A737-AB547E487217 Q43959176-82F96913-D87E-4AA3-8DB3-2E1FE3E8B634 Q46829177-7C156FBF-86DE-49FC-9A6C-F0344FC7ACF7 Q46844432-232A53F2-1309-41A7-9D1C-E80D1FC05AD1 Q47657351-785677A7-D281-42FF-9880-2DDE4A5D10F0 Q48098899-FB34D339-BF6A-4D17-9389-516D9AA1E1A9

P2860

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

http://www.wikidata.org/entity/Q36274606

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@ast

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@en

type

label

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@ast

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@en

prefLabel

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@ast

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@en

P1433

Q36274606-82FDF5E0-4257-488C-9466-09403DB21324

P1476

Q36274606-3557E572-E28C-49FE-8E1C-747169F600F8

P2093

Q36274606-0348532E-A7F8-454E-AEE5-32FEF1190668

Q36274606-1FCC17A1-45FF-44F8-8D98-A018E1DA261E

Q36274606-70026F32-0C9B-449C-BEE0-DBE0005E5ACB

Q36274606-784A69AE-3DA1-414F-AFEB-0AC038E6A35B

Q36274606-89C2705C-2D5A-45CC-887E-A2B344A024E0

Q36274606-B5726ED1-BCE0-45F8-9577-5698B352C2F9

Q36274606-C71A8F24-C74D-4EB2-9E41-16D780EE4231

Q36274606-CF7B7845-7F26-443B-9BD2-C231841E794A

Q36274606-D038615F-91F0-4437-B504-EB69576046A1

P2860

Q36274606-05BAD61E-828F-4BFF-9148-5465C3BCE5F1

Q36274606-21AC90D9-270F-4AE3-8828-9CEF7599BEEE

Q36274606-22F1B240-738F-439E-852C-F66A4CAB2E51

Q36274606-46E453B6-4D9D-48CE-BB95-4B5FC5633724

Q36274606-47035E9D-EFE2-472F-8D6F-02E310FB9C85

Q36274606-7045E5A4-86ED-4E1D-A0CB-CC04D304996D

Q36274606-71B656A7-A2B2-4CCA-8837-55123E58B975

Q36274606-7E0EEA8D-B0E7-4515-BCE3-BE09D975BE39

Q36274606-810AC453-2FE8-45AA-B2B5-E1CE651AE219

Q36274606-9CBC5E8F-4FB3-4088-AB30-9184D3FEB805

P304

Q36274606-0D8262DC-D038-4E68-9BC1-82F128828FB6

P31

Q36274606-52F95C93-9EF2-4EDC-AA5A-E0457F07B491

P356

Q36274606-AE7F449C-8E76-4EA9-967E-6412503EB87B

P407

Q36274606-B901786B-1B64-4879-9BE1-0D90CCC87678

P433

Q36274606-3A822E2E-9CA5-4F34-A8F5-6239C7C2799C

P478

Q36274606-1C704F6D-ADF7-4375-8445-2702581E5FE8

P577

Q36274606-0D28673D-1317-46CD-9A27-42C22D3524C2

P5875

Q36274606-3B215BB9-0382-4516-8B38-DC4AD34B0E54

P698

Q36274606-A241DFEC-95E4-4668-B533-AD907E51C3A3

P921

Q36274606-FF4E0DFC-32BF-4CF2-A051-ACA8AEF2718D

P932

Q36274606-D5F02C49-1A8C-4F64-8452-D1E00F952260

P356

P1433

P1476

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

@en

P2093

Flannery EM

http://www.w3.org/2001/XMLSchema#string

Herbison GP

http://www.w3.org/2001/XMLSchema#string

Lake DC

http://www.w3.org/2001/XMLSchema#string

Li Q

http://www.w3.org/2001/XMLSchema#string

Lucas MK

http://www.w3.org/2001/XMLSchema#string

Print CG

http://www.w3.org/2001/XMLSchema#string

Sears MR

http://www.w3.org/2001/XMLSchema#string

Taylor DR

http://www.w3.org/2001/XMLSchema#string

Yates DM

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of several tests for censored paired data.

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.

Is current treatment increasing asthma mortality and morbidity?

Increase in hospital admissions for childhood asthma: trends in referral, severity, and readmissions from 1970 to 1985 in a health region of the United Kingdom.

Regular inhaled beta-agonist treatment in bronchial asthma.

Evaluation of oral fenoterol in chronic asthmatic patients.

Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics. A double-blind crossover study.

Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

P304

134-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.48.2.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

1993-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14704942

http://www.w3.org/2001/XMLSchema#string

P698

8493626

http://www.w3.org/2001/XMLSchema#string

P921

P932

464288

http://www.w3.org/2001/XMLSchema#string